ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
NACRES:
NA.41
UNSPSC Code:
12352203
Clone:
114C307, monoclonal
Species reactivity:
human
Application:
Citations:
76
製品名
Anti-Noxa Mouse mAb (114C307), liquid, clone 114C307, Calbiochem®
biological source
mouse
antibody form
purified antibody
antibody product type
primary antibodies
clone
114C307, monoclonal
form
liquid
contains
≤0.1% sodium azide as preservative
species reactivity
human
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
avoid repeated freeze/thaw cycles
dilution
(Immunoblotting (1-2 µg/mL, chemiluminescence))
isotype
IgG1
shipped in
wet ice
storage temp.
−20°C
target post-translational modification
unmodified
Quality Level
Gene Information
human ... PMAIP1(5366)
Analysis Note
Negative Control
Normal mouse serum
Normal mouse serum
Positive Control
RL-7 cell lysate
RL-7 cell lysate
Application

Immunoblotting (1-2 g/ml, chemiluminescence)
Disclaimer
Toxicity: Standard Handling (A)
General description
Purified mouse monoclonal antibody. Recognizes the ~11 kDa Noxa protein.
Recognizes the ~11 kDa Noxa protein in RL-7 cells.
This Anti-Noxa Mouse mAb (114C307) is validated for use in Immunoblotting for the detection of Noxa.
Immunogen
Human
a recombinant protein consisting of human Noxa fused to GST
Other Notes
Antibody should be titrated for optimal results in individual system.
Oda, E., et al. 2000. Science288, 1053.
Packaging
Please refer to vial label for lot-specific concentration.
Physical form
In PBS, 0.05% BSA.
Preparation Note
Following initial thaw, aliquot and freeze (-20°C;)
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
適切な製品が見つかりませんか。
製品選択ツール.をお試しください
保管分類
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
OP180-UG: + OP180-100UG:
jan
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma.
Nabanita Mukherjee et al.
Cancers, 12(8) (2020-08-09)
There is an urgent need to develop treatments for patients with melanoma who are refractory to or ineligible for immune checkpoint blockade, including patients who lack BRAF-V600E/K mutations. This is often the case in patients diagnosed with rare melanoma subtypes
Tao Hu et al.
Molecular carcinogenesis, 58(1), 42-54 (2018-09-06)
Increasing evidence suggests that deubiquitinase USP7 participates in tumor progression by various mechanisms and serves as a potential therapeutic target. However, its expression and role in esophageal cancer remains elusive; the anti-cancer effect by targeting USP7 still needs to be
Santi Rello-Varona et al.
Scientific reports, 9(1), 3816-3816 (2019-03-09)
Soft-tissue sarcomas (STS) are an uncommon and heterogeneous group of malignancies that result in high mortality. Metastatic STS have very bad prognosis due to the lack of effective treatments. Dinaciclib is a model drug for the family of CDK inhibitors.
Min Ji Seo et al.
Cell death & disease, 10(3), 187-187 (2019-02-24)
Gambogic acid (GA), a xanthonoid extracted from the resin of the tree, Garcinia hanburyi, was recently shown to exert anticancer activity in multiple studies, but the underlying action mechanism remains unclear. Here, we show that GA induces cancer cell death
Mateus Milani et al.
Cell death discovery, 5, 117-117 (2019-07-26)
Maintenance of mitochondrial integrity is critical for normal cellular homoeostasis. Most cells respond to stress stimuli and undergo apoptosis by perturbing mitochondrial structure and function to release proteins, such as cytochrome c, which are essential for the execution of the
グローバルトレードアイテム番号
| カタログ番号 | GTIN |
|---|---|
| OP180-100UGCN | 04055977208849 |
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)